Documents & Downloads

Acmopatide

GIP/GLP-1 Receptor Agonist

Acmopatide is a dual-acting agonist of the GIP and GLP-1 receptors. This compound exhibits significant biological activity in enhancing insulin secretion and regulating glucose homeostasis, making it a valuable tool in anti-diabetic research. Its unique mechanism of action supports investigations into novel therapeutic approaches for diabetes management.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Agonist
CAS Number	2377239-31-9
Applications	GIP/GLP-1 Receptor Agonist
Formula	C₂₁₄H₃₂₃N₄₇O₆₄S
Molecular Weight	4610.20

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.